ACTIVE

Het Apothekershuis

Financial year 2025 · Closed on 31/12/2025

Net result275,7 k €+78,6 %over 1 year
Gross margin418,2 k €+24,0 %over 1 year
Equity1,1 M €-17,1 %over 1 year
Workforce1,7 ETP0,0 %over 1 year

Identity

Source · BCE/KBO

Het Apothekershuis is a Private limited company incorporated in 2003. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Bree. It employs on average 1,7 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0861.964.170
Incorporation
01/12/2003
Legal form
Private limited company
Registered office
Kloosterstraat 11
3960 Bree · FlandreSee on map
Contributed capital
394 800,00 €
Latest accounts
31/12/2025
Average workforce
1,7 ETP
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 21 filings

Trend over 18 financial years

20252024202320222021
Income statement
Gross margin418,2 k €337,2 k €274,6 k €221,8 k €171,6 k €
EBITDA333,9 k €254 k €190,3 k €158,8 k €104,4 k €
Operating result324,5 k €208 k €146,6 k €119,1 k €66,9 k €
Net result275,7 k €154,4 k €106,3 k €106,9 k €50,2 k €
Balance sheet
Equity1,1 M €1,3 M €1,2 M €1 M €960,8 k €
Total assets1,8 M €1,8 M €1,7 M €1,7 M €1,6 M €
Cash731,9 k €317,5 k €135,3 k €217,3 k €100,9 k €
Debts691,4 k €514,5 k €530,9 k €687,1 k €619 k €
Other
Workforce1,7 ETP1,7 ETP1,7 ETP1,5 ETP1,8 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 2,5 M€ and 5 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 7 ended

Active mandates

met Apotheken

Director · since 01 juillet 2025 · 0782.370.920

Active

Ended mandates

A. JANS PHARMA

Director · since 01 octobre 2020 · 0754.509.847

Represented by Jans Andrea

Ended
A. JANS PHARMA

Vast vertegenwoordiger rechtspersoon · since 01 octobre 2020 · 0754.509.847

Represented by Andrea Jans

Ended
ANDREA JANS

Director · since 01 octobre 2020

Ended
Caroline Vandierendonck

Manager

Ended

Other companies at this address

Kloosterstraat 11 3960 Bree
CompanyCBE no.
A. JANS PHARMA● Active
0754.509.847

Full financial information

Source · NBB
202520242023202220212020
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date28/07/202627/08/202518/09/202430/08/202331/08/202231/08/2021
General meeting10/06/202611/06/202512/06/202414/06/202308/06/202209/06/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 21 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202510/06/202628/07/2026DutchPDF
Abridged model31/12/202411/06/202527/08/2025DutchPDF
Abridged modelCorrection31/12/202312/06/202418/09/2024DutchPDF
Abridged model31/12/202312/06/202416/09/2024DutchPDF
Abridged model31/12/202214/06/202330/08/2023DutchPDF
Abridged model31/12/202108/06/202231/08/2022DutchPDF
Abridged model31/12/202009/06/202131/08/2021DutchPDF
Abridged model31/12/201910/06/202016/06/2020DutchPDF
Abridged model31/12/201812/06/201921/06/2019DutchPDF
Abridged model31/12/201713/06/201826/06/2018DutchPDF
Abridged model31/12/201630/06/201725/09/2017DutchPDF
Abridged model31/12/201530/06/201615/07/2016DutchPDF
Abridged model31/12/201430/06/201524/09/2015DutchPDF
Abridged model31/12/201330/06/201406/08/2014DutchPDF
Abridged model31/12/201230/06/201310/09/2013DutchPDF
Abridged model31/12/201118/07/201224/07/2012DutchPDF
Abridged model31/12/201001/06/201121/06/2011DutchPDF
Abridged model31/12/200923/06/201029/06/2010DutchPDF
Abridged model31/12/200824/06/200909/07/2009DutchPDF
Abridged model31/12/200725/06/200826/06/2008DutchPDF
Abridged model31/12/200627/06/200728/06/2007DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 2,5 M€ and 5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 7 ended

Active mandates

met Apotheken

Director · since 01 juillet 2025 · 0782.370.920

Active

Ended mandates

A. JANS PHARMA

Director · since 01 octobre 2020 · 0754.509.847

Represented by Jans Andrea

Ended
A. JANS PHARMA

Vast vertegenwoordiger rechtspersoon · since 01 octobre 2020 · 0754.509.847

Represented by Andrea Jans

Ended
ANDREA JANS

Director · since 01 octobre 2020

Ended
Caroline Vandierendonck

Manager

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates31/07/2025
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Other18/11/2020
    BENAMING
    PDF
  • Mandates13/10/2020
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Restructuring14/09/2020
    DOEL - KAPITAAL - AANDELEN - ONTSLAGEN - BENOEMINGEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
    PDF
  • Restructuring10/07/2020
    WIJZIGING RECHTSVORM - RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
    PDF
  • Mandates31/05/2017
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Capital / shares24/01/2014
    KAPITAAL - AANDELEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …)
    PDF
  • Mandates18/01/2008
    ONTSLAGEN - BENOEMINGEN
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025275,7 k €↑
  2. 2024
    Annual accounts 2024154,4 k €↑
  3. 2023
    Annual accounts 2023106,3 k €↓
  4. 2022
    Annual accounts 2022106,9 k €↑
  5. 2021
    Annual accounts 202150,2 k €↑
  6. 2018
    Annual accounts 201849,6 k €↓
  7. 2017
    Annual accounts 201755,6 k €↑
  8. 2016
    Annual accounts 201638,7 k €↓
  9. 2015
    Annual accounts 201565,4 k €↓
  10. 2014
    Annual accounts 201476,8 k €↑
  11. 2013
    Annual accounts 201374,2 k €↓
  12. 2012
    Annual accounts 201293,8 k €↑
  13. 2011
    Annual accounts 201190,7 k €↑
  14. 2010
    Annual accounts 201053,9 k €↓
  15. 2009
    Annual accounts 200955,4 k €↓
  16. 2008
    Annual accounts 200855,7 k €↑
  17. 2007
    Annual accounts 200753,1 k €↓
  18. 2006
    Annual accounts 200656,1 k €
  19. 01/12/2003
    IncorporationPrivate limited company